RevMed

Home/Brands/BIOMERIEUX SA

BIOMERIEUX SA

Main Filters

BIOMERIEUX SA

BIOMERIEUX SA
CATALOG #	QTY	PRICE	DESCRIPTION
1.0	0	-	Software used in combination with the THxIDTM- BRAF assay(used to identify patients with melanoma whose tumors harbor the BRAF V600E/K mutations)
chromID® MRSA agar	0	-	Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus (MRSA)
chromID™ MRSA /SAID	0	-	Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus and selective isolation of staphylococci and the direct identification of S. aureus.
chromID™ VRE Agar	0	-	Chromogenic medium for the qualitative detection of Enterococcus faecium and E. faecalis showing acquired vancomycin resistance (VRE) in stool specimens.
ETEST® Amoxicillin/clavulanic acid (2/1) (XL)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ampicillin (AM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Aztreonam (AT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftazidime/Avibactam (CZA)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftolozane/Tazobactam (C/T)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefuroxime (XM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Chloramphenicol (CL)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ciprofloxacin (CI)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Clindamycin (CM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Daptomycin (DPC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Doripenem (DOR)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ertapenem (ETP)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Erythromycin (EM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Fluconazole (FL)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Flucytosine (FC)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® GATIFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® GEMIFLOXACIN	0	-	GEMIFLOXACIN GEM 32 US S30
ETEST® Gentamicin (GM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Imipenem (IP)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Itraconazole (IT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Levofloxacin (LE)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Linezolid (LZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Meropenem (MP)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Metronidazole (MZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Minocycline (MC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Moxifloxacin (MX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ofloxacin (OF)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Oxacillin (OX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® PIP/TAZO/CON-4	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Piperacillin (PP)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Piperacillin/Tazobactam (P/T)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Quinupristin/Dalfopristin (QDA)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Rifampicin (RI)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Telavancin (TLA)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Tetracycline (TC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ticarcillin/clavulanic acid (TLC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIGECYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Tobramycin (TM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Trimethoprim (TR)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Vancomycin (VA)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Voriconazole (VO)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
VIDAS® Serum Free	0	-	The Serum free reagent can be used with VIDAS ® assays for which its use is clearly indicated in the VIDAS assay package insert.
VITEK® MS CHCA	0	-	The VITEK MS-CHCA matrix is used with the VITEK® MS System to enable identification of microorganisms. The matrix absorbs energy from the VITEK MS laser and transfers it to the microorganisms
VITEK® MS FA	0	-	VITEK ® MS - FA is used to pretreat yeasts to facilitate their identification according to the MALDI - TOF method. It is used exclusively with the VITEK ® MS instrument.
VITEK® MS-DS	0	-	The VITEK MS-DS target slides enable the identification of microorganisms according to the MALDI-TOF mass spectrometry method.

326 Results

Results Per Page

Catalog #

AvailableQty

Starting At

Name

Company Name

Description

ETEST® Piperacillin/Tazobactam (P/T)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

1.0

THxID™ BRAF

BIOMERIEUX SA

Software used in combination with the THxIDTM- BRAF assay(used to identify patients with melanoma whose tumors harbor the BRAF V600E/K mutations)

VITEK® MS CHCA

BIOMERIEUX SA

The VITEK MS-CHCA matrix is used with the VITEK® MS System to enable identification of microorganisms. The matrix absorbs energy from the VITEK MS laser and transfers it to the microorganisms

ETEST® Aztreonam (AT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

VITEK® MS FA

BIOMERIEUX SA

VITEK ® MS - FA is used to pretreat yeasts to facilitate their identification according to the MALDI - TOF method. It is used exclusively with the VITEK ® MS instrument.

VITEK® MS-DS

BIOMERIEUX SA

The VITEK MS-DS target slides enable the identification of microorganisms according to the MALDI-TOF mass spectrometry method.

chromID™ VRE Agar

CHROMID® VRE Agar

BIOMERIEUX SA

Chromogenic medium for the qualitative detection of Enterococcus faecium and E. faecalis showing acquired vancomycin resistance (VRE) in stool specimens.

chromID® MRSA agar

CHROMID® MRSA agar

BIOMERIEUX SA

Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus (MRSA)

chromID™ MRSA /SAID

BIOMERIEUX SA

Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus and selective isolation of staphylococci and the direct identification of S. aureus.

VIDAS® Serum Free

BIOMERIEUX SA

The Serum free reagent can be used with VIDAS ® assays for which its use is clearly indicated in the VIDAS assay package insert.

ETEST® Ampicillin (AM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Amoxicillin/clavulanic acid (2/1) (XL)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Telavancin (TLA)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ceftolozane/Tazobactam (C/T)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® GEMIFLOXACIN

BIOMERIEUX SA

GEMIFLOXACIN GEM 32 US S30

ETEST® Doripenem (DOR)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Daptomycin (DPC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIGECYCLINE

ETEST® Tigecycline (TGC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Voriconazole (VO)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ertapenem (ETP)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Linezolid (LZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® GATIFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Metronidazole (MZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Moxifloxacin (MX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Quinupristin/Dalfopristin (QDA)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Levofloxacin (LE)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Rifampicin (RI)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Itraconazole (IT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Vancomycin (VA)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Trimethoprim (TR)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ticarcillin/clavulanic acid (TLC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Tetracycline (TC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Tobramycin (TM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Piperacillin (PP)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® PIP/TAZO/CON-4

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Oxacillin (OX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ofloxacin (OF)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Minocycline (MC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Meropenem (MP)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Imipenem (IP)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Gentamicin (GM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Flucytosine (FC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Fluconazole (FL)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Erythromycin (EM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Clindamycin (CM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ciprofloxacin (CI)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Chloramphenicol (CL)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefuroxime (XM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ceftazidime/Avibactam (CZA)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.